neurodegenerative diseases

Ferrer nabs European rights for ALS asset in €500M pact

Ferrer is paying 80 million euros upfront to jointly develop neurodegenerative disease candidate pridopidine in Europe with Dutch biotech Prilenia Tx.

Darren Incorvaia Apr 28, 2025 2:40pm

GSK pens $2.5B pact for ABL's blood-brain barrier-bypassing tech

Apr 7, 2025 7:00am

Investment firm secures $250M to help fund dementia drug R&D

Mar 20, 2025 2:53pm

Oligomerix small molecule tamps down tau tangles in mice

Mar 14, 2025 12:30pm

An artists depiction of DNA molecules made up of tiny particles

Oligonucleotide stops gene expansion driving Huntington's: study

Feb 12, 2025 2:00pm

bad sleep sleep disorder timeline alarm clock deadline

Hormone therapies help mice with ALS get better sleep: study

Jan 29, 2025 2:00pm